These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16928343)

  • 1. The pleomorphic pathology of inherited Parkinson's disease: lessons from LRRK2.
    Bonifati V
    Curr Neurol Neurosci Rep; 2006 Sep; 6(5):355-7. PubMed ID: 16928343
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advance of the study on LRRK2 gene in Parkinson's disease].
    Zhang Y; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):657-9. PubMed ID: 19065525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease.
    Greggio E
    Biochem Soc Trans; 2012 Oct; 40(5):1058-62. PubMed ID: 22988865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of Parkinson's disease: LRRK2 on the rise.
    Brice A
    Brain; 2005 Dec; 128(Pt 12):2760-2. PubMed ID: 16311269
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenesis of Parkinson's disease through LRRK2 mutation].
    Ohta E; Obata F
    Seikagaku; 2014 Feb; 86(1):92-7. PubMed ID: 24693706
    [No Abstract]   [Full Text] [Related]  

  • 6. Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.
    Greggio E; Cookson MR
    ASN Neuro; 2009 Apr; 1(1):. PubMed ID: 19570025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK2 Parkinson's disease: from animal models to cellular mechanisms.
    Lin CH; Tsai PI; Wu RM; Chien CT
    Rev Neurosci; 2011; 22(4):411-8. PubMed ID: 21679126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
    Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.
    Gaig C; Martí MJ; Ezquerra M; Rey MJ; Cardozo A; Tolosa E
    J Neurol Neurosurg Psychiatry; 2007 Jun; 78(6):626-8. PubMed ID: 17210620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics.
    Bonifati V
    Eur J Hum Genet; 2006 Oct; 14(10):1061-2. PubMed ID: 16835587
    [No Abstract]   [Full Text] [Related]  

  • 11. Wild-type LRRK2 as a new potential therapeutic target in idiopathic Parkinson's disease.
    Sanjari Moghaddam H; Aarabi MH
    Mov Disord; 2018 Dec; 33(12):1876. PubMed ID: 30452792
    [No Abstract]   [Full Text] [Related]  

  • 12. LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease.
    Elbaz A
    Lancet Neurol; 2008 Jul; 7(7):562-4. PubMed ID: 18539536
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.
    Giordana MT; D'Agostino C; Albani G; Mauro A; Di Fonzo A; Antonini A; Bonifati V
    Mov Disord; 2007 Jan; 22(2):275-8. PubMed ID: 17149743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRK2 as a therapeutic target in Parkinson's disease.
    Tan EK; Schapira AH
    Eur J Neurol; 2011 Apr; 18(4):545-6. PubMed ID: 21199179
    [No Abstract]   [Full Text] [Related]  

  • 15. LRRK2 mutations in Basque patients with Parkinson's disease.
    Zarranz JJ; Gómez-Esteban JC
    Lancet Neurol; 2008 Oct; 7(10):866-7; author reply 867. PubMed ID: 18848304
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular effects of LRRK2 mutations.
    Cookson MR
    Biochem Soc Trans; 2012 Oct; 40(5):1070-3. PubMed ID: 22988867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: The G2019S LRRK2 mutation is uncommon amongst Greek patients with familial Parkinson's disease.
    Papapetropoulos S; Argyriou AA; Mitsi G; Chroni E
    Eur J Neurol; 2007 Nov; 14(11):e6. PubMed ID: 17956439
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mutation in LRRK2 is associated with familial presentation of Parkinson's disease in a Chilean kindred].
    Miranda M
    Rev Med Chil; 2007 Mar; 135(3):406-7. PubMed ID: 17505590
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.
    Brockmann K; Gröger A; Di Santo A; Liepelt I; Schulte C; Klose U; Maetzler W; Hauser AK; Hilker R; Gomez-Mancilla B; Berg D; Gasser T
    Mov Disord; 2011 Nov; 26(13):2335-42. PubMed ID: 21989859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The G2019S LRRK2 mutation: another morbid burden for Ashkenazi Jews may provide new insights on sporadic Parkinson's disease.
    Melamed E
    Mov Disord; 2013 Dec; 28(14):1912-4. PubMed ID: 24307480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.